<!DOCTYPE html>
<!--[if lte IE 8]> <html class="no-js lt-ie9 microsite" lang="de"> <![endif]-->
<!--[if lte IE 9]> <html class="no-js lt-ie10 microsite" lang="de"> <![endif]-->
<!--[if gt IE 9]><!--> <html class="no-js microsite" lang="de"> <!--<![endif]-->
<head>

<meta charset="utf-8">
<!-- 
	############################################################
	Made by artplan[21] GmbH, Berlin (Germany), www.artplan21.de
	############################################################

	This website is powered by TYPO3 - inspiring people to share!
	TYPO3 is a free open source Content Management Framework initially created by Kasper Skaarhoj and licensed under GNU/GPL.
	TYPO3 is copyright 1998-2015 of Kasper Skaarhoj. Extensions are copyright of their respective owners.
	Information and contribution at http://typo3.org/
-->

<base href="http://artplan21.github.io/charite-microsite-prototype/">

<title>Charité - Universitätsmedizin Berlin: Publikationen der Klinik (2004-2014)</title>
<meta name="generator" content="TYPO3 CMS">


<link rel="stylesheet" type="text/css" href="typo3conf/ext/a21_custom/Resources/Public/css/powermail.css?1445584025" media="all">
<!--[if lte IE 8]><link rel="stylesheet" type="text/css" href="typo3conf/ext/a21_custom/Resources/Public/css/all-old-ie.css?1447780987" media="all"><![endif]-->
<!--[if gt IE 8]><!--><link rel="stylesheet" type="text/css" href="typo3conf/ext/a21_custom/Resources/Public/css/main.css?1447780987" media="all"><!--<![endif]-->
<link rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,500" media="all">
<link rel="stylesheet" type="text/css" href="typo3conf/ext/a21_custom/Resources/Public/css/hotfix2.css?1445413383" media="all">



<!--[if lte IE 8]><script src="typo3conf/ext/a21_custom/Resources/Public/js/libs/vendor/html5shiv/html5shiv.min.js?1443453173" type="text/javascript"></script><![endif]-->
<!--[if lte IE 8]><script src="typo3conf/ext/a21_custom/Resources/Public/js/libs/vendor/html5shiv/html5shiv-printshiv.js?1443453173" type="text/javascript"></script><![endif]-->


<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-status-bar-style" content="black"><link rel="stylesheet" href="typo3conf/ext/a21_gcs_charite/Resources/Public/Css/default+de_Patched.css">
<meta name="description" content="Informationen zum Leistungsspektrum der Charité - Universitätsmedizin Berlin für Patienten, Ärzte, Studierende und Wissenschaftler">
<meta name="keywords" content="Charité - Universitätsmedizin Berlin, Universitätsklinikum, Wissenschaft, Forschung, Medizin, Patient">
<meta name="author" content="Charité - Universitätsmedizin Berlin 2011">
<meta name="rating" content="General">
<meta name="robots" content="noindex,nofollow,noodp,noydir">
<meta name="revisit-after" content="3">
<link rel="canonical" href="http://relaunch-strahlentherapie.charite.juno.artplan.local/forschung/publikationen/publikationen_der_klinik_2004_2014/">
</head>
<body class="color-pattern-6">

<div class="total-wrapper">

	
<!--[if lt IE 8]>
		<p class="browsehappy">Sie verwenden einen <strong>veralteten</strong> Browser. Bitte <a href="http://browsehappy.com/" target="_blank"  rel="nofollow">aktualisieren Sie Ihren Browser</a> um die Seite richtig darstellen zu können.</p>
		<![endif]-->
		<noscript>
			<p><strong>JavaScript scheint in Ihrem Browser deaktiviert zu sein.</strong></p>
			<p>Sie müssen JavaScript in Ihrem Browser aktivieren um alle Funktionen der Seite nutzen zu können.</p>
		</noscript>
		<h4 class="hidden-text">Herzlich Willkommen auf den Internetseiten der Charité - Universitätsmedizin Berlin, einer gemeinsamen Einrichtung der Freien Universität Berlin und der Humboldt-Universität zu Berlin.</h4>
		<!-- mod-skiplinks:start -->
		<p class="hidden-text">Um direkt zu entsprechenden Bereichen zu springen verwenden Sie die Sprungmarken wie folgt:</p><ul class="skiplinks"><li><a href="/" accesskey="0" title="[ALT + 0]">Direkt zur Eingangsseite</a><span>.</span></li>
			<li><a href="forschung/publikationen/publikationen_der_klinik_2004_2014/#navigationmark" accesskey="1" title="[ALT + 1]">Direkt zur Navigation</a><span>.</span></li>
			<li><a href="forschung/publikationen/publikationen_der_klinik_2004_2014/#main" accesskey="2" title="[ALT + 2]">Direkt zum Inhalt</a><span>.</span></li><li><a href="https://relaunch-strahlentherapie.charite.juno.artplan.local/service/kontakt/" accesskey="3" title="[ALT + 3]">Direkt zum Kontakt</a></li><li><a href="service/suche/" accesskey="4" title="[ALT + 4]">Direkt zur Suche</a></li><li><a href="service/notfall/" accesskey="5" title="[ALT + 5]">Direkt zur Notfallseite</a></li><li><a href="service/glossar/" accesskey="6" title="[ALT + 6]">Direkt zum Glossar</a></li><li><a href="service/impressum/" accesskey="7" title="[ALT + 7]">Direkt zum Impressum</a></li><li><a href="service/sitemap/" accesskey="8" title="[ALT + 8]">Direkt zur Sitemap</a></li></ul><!-- mod-skiplinks:end -->


	<div class="page-wrapper">
		<!-- wrapper:start -->
		<div class="wrapper">

			
<!-- mod-meta-navigation:start -->
<div class="max-width">
	<!--<span class="btn-meta-menu"></span>--><div class="mod-meta-navigation">
				<h4 class="hidden-text">Metanavigation:</h4><p class="hidden-text">Hier finden Sie den Zugang zur Notfallseite, Kontaktinformationen, Barrierefreiheits-Einstellungen, die Sprachwahl und die Suchfunktion.</p>
				<ul class="meta-list"><li class="contact"><!-- flyout-contact:start --><a href="forschung/publikationen/publikationen_der_klinik_2004_2014/#" title="Kontaktmöglichkeiten"><span>Charité kontaktieren:</span></a><div class="flyout"><div class="flyout-content"><ul><li><a class="icon-phone" href="tel:" title="Anrufen"><span>t: +49 30 450-5</span></a></li><li><a href="https://relaunch-strahlentherapie.charite.juno.artplan.local/service/kontakt/" class="icon-mail" title="E-Mail schreiben"><span>Kontakt aufnehmen</span></a></li><li><a href="ihre_ansprechpartner_an_der_charite/" class="icon-expert" title="zur Ansprechpartner-Seite"><span>Ansprechpartner</span></a></li></ul><p><strong>Anschrift:</strong>							Charit&eacute;platz1<br>
							10117 Berlin</p><ul><li><strong>Unsere Standorte:</strong></li><li><a href="die_charite/standorte/campus_benjamin_franklin/" class="icon-locations"><span>Campus Benjamin Franklin (CBF)</span></a></li><li><a href="die_charite/standorte/campus_berlin_buch/" class="icon-locations"><span>Campus Berlin Buch (CBB)</span></a></li><li><a href="die_charite/standorte/campus_charite_mitte/" class="icon-locations"><span>Campus Charit&eacute; Mitte (CCM)</span></a></li><li><a href="die_charite/standorte/campus_virchow_klinikum/" class="icon-locations"><span>Campus Virchow-Klinikum (CVK)</span></a></li></ul></div></div><!-- flyout-contact:end --></li><li class="accessibility">
				<!-- flyout-accessibility:start -->
				<a href="forschung/publikationen/publikationen_der_klinik_2004_2014/#" title="Seiten-Einstellungen"><span>Benutzerfreundlichkeit:</span></a>
				<div class="flyout">
					<div class="flyout-content">
						<!-- mod-contrast:start -->
						<div class="mod-contrast">
							<span class="icon-after icon-lesscontrast">Kontraststärke</span>
							<span class="switch">Kontrastschalter</span>
							<span class="icon-after icon-morecontrast"></span>
						</div>
						<!-- mod-contrast:end -->

						<!-- mod-fontsize:start -->
						<div class="mod-fontsize">
							<span>Schriftgröße</span>
							<div class="wrap-button">
								<span class="hidden-text">Schrift vergrößern:</span>
								<span class="btn-keyboard">STRG</span><span class="btn-keyboard">+</span>
								<span class="hidden-text">Schrift verkleinern:</span>
								<span class="btn-keyboard">STRG</span><span class="btn-keyboard">-</span>
							</div>
							<p>Sie können die Seite mithilfe Ihres Browsers größer oder kleiner anzeigen lassen. Verwenden Sie dafür bitte STRG + und STRG - . Mit STRG 0 gelangen Sie wieder zur Ausgangsgröße.</p>
						</div>
						<!-- mod-fontsize:end -->
					</div>
				</div>
				<!-- flyout-accessibility:end -->
			</li><li class="language"><!-- flyout-language:start --><a href="forschung/publikationen/publikationen_der_klinik_2004_2014/#" title="Sprach-Einstellung"><span class="hidden-text">Aktuelle Spracheinstellung:</span><span>DE</span></a><div class="flyout"><div class="flyout-content"><!-- mod-language:start --><div class="mod-language"><h4 class="hidden-text">Spracheinstellungen ändern auf:</h4><ul><li class="de active">Deutsch</li><li class="en active">Englisch</li><li class="ru active">Russisch</li></ul></div><!-- mod-language:end --></div></div><!-- flyout-language:end --></li></ul>
		</div><ul>
				<li class="search">
					<span class="hidden-text">Auf der Seite suchen:</span>
					<!-- flyout-mod-search:start -->
					<div class="mod-search" title="Suchen">
						<form action="service/suche/" method="get">
							<div class="field">
								<input name="q" id="globalSearch" type="search" autocomplete="on" placeholder="Suchbegriff eingeben">
							</div>
							<button type="submit">
								<span class="hidden-text">Suche absenden</span>
							</button>
							<span class="search-toggle">
								<span class="hidden-text">Suchfeld öffnen und schließen</span>
							</span>
							<input type="hidden" value="" name="as_sitesearch_box" />
							<input type="hidden" value="014718619165564365362:wzuiafecgo4" id="cx_box" /><!--  name is missing for a reason, hardcoded value, please forgive me -->
						</form>
					</div>
					<!-- flyout-mod-search:end -->
				</li>
			</ul></div>
<!-- mod-meta-navigation:end -->

<!-- header:start -->
<header>
	<!-- logo:start -->
	<div class="logo">
		
			<a href="/">Charité - Universitätsmedizin Berlin</a>
		
	</div>
	<div class="sitename color-pattern-1">Klinik für Radioonkologie und Strahlentherapie</div>
	<!-- logo:end -->
	
  <!-- navigation:start -->
    <span class="nav-toggle">Navigation öffnen</span>
    <nav role="navigation" id="navigationmark">
      <h4 class="hidden-text">Zielgruppen- und Bereichsnavigation:</h4>
      <ul>
        <li class="color-pattern-1"><div><dfn class="menu">1:</dfn><a href="/"><p>Startseite</p></a></div></li><li class="color-pattern-1"><div><dfn class="menu">2:</dfn><a href="fuer_patienten/"><p>Patienten</p></a></div></li><li class="color-pattern-1"><div><dfn class="menu">3:</dfn><a href="fuer_aerzte/"><p>Ärzte</p></a></div></li><li class="color-pattern-1"><div><dfn class="menu">4:</dfn><a href="fuer_studierende/"><p>Forschung &amp; Lehre</p></a></div></li><li class="color-pattern-1"><div class="active-level"><dfn class="menu">5:</dfn><a href="forschung/"><p>Behandlungsangebote</p></a></div><ul class="flyout"><li><div class="active-level level-2"><dfn class="menu">5.1:</dfn><a href="forschung/publikationen/"><p>Publikationen</p></a></div><ul class="flyout"><li><div class="active active-level level-3 icon-after"><dfn class="menu">5.1.1:</dfn><p>Publikationen der Klinik (2004-2014)</p></div></li><li><div class="level-3 icon-after"><dfn class="menu">5.1.2:</dfn><a href="forschung/publikationen/prof_dr_med_simone_marnitz/"><p>Prof. Dr. med Simone Marnitz</p></a></div></li><li><div class="level-3 icon-after"><dfn class="menu">5.1.3:</dfn><a href="forschung/publikationen/priv_doz_dr_med_harun_badakhshi/"><p>Priv.-Doz. Dr. med. Harun Badakhshi</p></a></div></li></ul></li></ul></li><li class="color-pattern-1"><div><dfn class="menu">6:</dfn><a href="ueber_uns/"><p>Über uns</p></a></div></li><li class="color-pattern-7"><div><a href="metas/adresse/"><p>So finden Sie den<br/>Weg zu uns</p></a></div></li>
      </ul>
    </nav>
  <!-- navigation:end -->
  
</header>
<!-- header:end -->


			<!-- main:start -->
			<main id="main" role="main" class="show-grid">
				  <!--TYPO3SEARCH_begin-->

				<!-- mod-stage-static:start -->
				<section class="mod-stage-static stage-fullheight-image">
					<div class="row">
						
					</div>
				</section>
				<!-- mod-stage-static:end -->
			
				
			
				<div class="container">
					
<h2 class="csc-firstHeader" id="c196801">Publikationen der Klinik (2004-2014)</h2><p>Es handelt sich hierbei lediglich um Publikationen in den MedLine-indexierten Journalen.<br />Eine komplette Übersicht aller Publikation der Klinik wird erarbeitet.</p>
<p>1.&nbsp;Winkler C, Duma MN, Popp W, Sack H, Budach V, Molls M, et al. Protection of quality and innovation in radiation oncology : The prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014.</p>
<p>2.&nbsp;Vorwerk H, Zink K, Schiller R, Budach V, Bohmer D, Kampfer S, et al. Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014;190(5):433-43.</p>
<p>3.&nbsp;Tinhofer I, Saki M, Niehr F, Keilholz U, Budach V. Cancer stem cell characteristics of circulating tumor cells. International journal of radiation biology. 2014:1-6.</p>
<p>4.&nbsp;Tang HR, Ma HF, An SM, Badakhshi H, Deng JY, Zhang JH, et al. A Phase II Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin for Inoperable Esophageal Squamous Cell Carcinoma. American journal of clinical oncology. 2014.</p>
<p>5.&nbsp;Seidensticker M, Burak M, Kalinski T, Garlipp B, Koelble K, Wust P, et al. Radiation-Induced Liver Damage: Correlation of Histopathology with Hepatobiliary Magnetic Resonance Imaging, a Feasibility Study. Cardiovascular and interventional radiology. 2014.</p>
<p>6.&nbsp;Ruckert JC, Ismail M, Badakhshi H, Meisel A, Swierzy M. [In Process Citation]. Zentralblatt fur Chirurgie. 2014;139(1):121-32; quiz 33-4.</p>
<p>7.&nbsp;Neumann O, Kluge A, Lyubina O, Wlodarczyk W, Jahn U, Kohler C, et al. Robotic radiosurgery as an alternative to brachytherapy for cervical cancer patients. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014;190(6):538-45.</p>
<p>8.&nbsp;Nassir M, Roth A, Gasimli K, Braicu EI, Fotopoulou C, Mawrin C, et al. Is endometrial cancer really a neurophobic tumor? A case report and review of the literature. Anticancer research. 2014;34(1):249-57.</p>
<p>9.&nbsp;Muallem MZ, Marnitz S, Richter R, Kohler C, Sehouli J, Arsenic R. ERCC1 expression as a predictive marker of cervical cancer treated with cisplatin-based chemoradiation. Anticancer research. 2014;34(1):401-6.</p>
<p>10.&nbsp;Marnitz S, Zich A, Martus P, Budach V, Jahn U, Neumann O, et al. Long-term results of total body irradiation in adults with acute lymphoblastic leukemia. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014;190(5):453-8.</p>
<p>11.&nbsp;Marnitz S, Kohler C, Rauer A, Schneider A, Budach V, Tsunoda A, et al. Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014;190(1):34-40.</p>
<p>12.&nbsp;Keilholz U, Pezzutto A, Budach V, Eggert A. Long-term structured follow-up is essential after curative cancer treatment. Deutsches Arzteblatt international. 2014;111(1-2):1-2.</p>
<p>13.&nbsp;Kaul D, Fallenberg E, Diekmann F, Budach V, Maurer M. Dislocability of localization devices for nonpalpable breast lesions: experimental results. Radiology research and practice. 2014;2014:425823.</p>
<p>14.&nbsp;Kaul D, Budach V, Wurm R, Gruen A, Graaf L, Habbel P, et al. Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma. Radiation oncology. 2014;9(1):78.</p>
<p>15.&nbsp;Huber KJ, Wust PK, Rhode M, Overmann J, Foesel BU. Aridibacter famidurans and Aridibacter kavangonensis, 2 novel species of Acidobacteria subdivision 4 isolated from semiarid savanna soil. International journal of systematic and evolutionary microbiology. 2014.</p>
<p>16.&nbsp;Ghadjar P, Budach V, Zwahlen DR. RE: Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. Journal of the National Cancer Institute. 2014;106(3):djt464.</p>
<p>17.&nbsp;Foesel BU, Nagele V, Naether A, Wust PK, Weinert J, Bonkowski M, et al. Determinants of Acidobacteria activity inferred from the relative abundances of 16S rRNA transcripts in German grassland and forest soils. Environmental microbiology. 2014;16(3):658-75.</p>
<p>18.&nbsp;Dunst J, Willich N, Sack H, Engenhart-Cabillic R, Budach V, Popp W. The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014;190(2):138-48.</p>
<p>19.&nbsp;Donti TR, Stromberger C, Ge M, Eldin KW, Craigen WJ, Graham BH. Screen for abnormal mitochondrial phenotypes in mouse embryonic stem cells identifies a model for succinyl-CoA ligase deficiency and mtDNA depletion. Disease models &amp; mechanisms. 2014;7(2):271-80.</p>
<p>20.&nbsp;Collettini F, Lutter A, Schnapauff D, Hildebrandt B, Puhl G, Denecke T, et al. Unresectable Colorectal Liver Metastases: Percutaneous Ablation Using <abbr title="Computertomographie">CT</abbr>-Guided High-Dose-Rate Brachytherapy (<abbr title="Computertomographie">CT</abbr>-HDBRT). RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2014.</p>
<p>21.&nbsp;Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Gallotta V, et al. Pelvic Exenteration for Recurrent Endometrial Adenocarcinoma: A Retrospective Multi-institutional Study About 21 Patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2014;24(5):880-4.</p>
<p>22.&nbsp;Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Ferrandina G, et al. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2014;24(5):916-22.</p>
<p>23.&nbsp;Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Fagotti A, et al. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2014;24(1):156-64.</p>
<p>24.&nbsp;Budach V, Becker ET, Boehmer D, Badakhshi H, Jahn U, Wernecke KD, et al. Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014;190(3):250-5.</p>
<p>25.&nbsp;Badakhshi H, Muellner S, Wiener E, Budach V. Image-guided stereotactic radiotherapy for patients with vestibular schwannoma : A clinical study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014;190(6):533-7.</p>
<p>26.&nbsp;Badakhshi H, Graf R, Bohmer D, Synowitz M, Wiener E, Budach V. Results for local control and functional outcome after linac-based image-guided stereotactic radiosurgery in 190 patients with vestibular schwannoma. Journal of radiation research. 2014;55(2):288-92.</p>
<p>27.&nbsp;Apostolova I, Hofheinz F, Buchert R, Steffen IG, Michel R, Rosner C, et al. Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma : A PET/<abbr title="Computertomographie">CT</abbr> pilot study using [O]water and [ F]fluorodeoxyglucose. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2014;190(6):575-81.</p>
<p>28.&nbsp;Woitzik J, Hecht N, Pinczolits A, Sandow N, Major S, Winkler MK, et al. Propagation of cortical spreading depolarization in the human cortex after malignant stroke. Neurology. 2013;80(12):1095-102.</p>
<p>29.&nbsp;Winter L, Ozerdem C, Hoffmann W, Santoro D, Muller A, Waiczies H, et al. Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla. PloS one. 2013;8(4):e61661.</p>
<p>30.&nbsp;Stromberger C, Gruen A, Wlodarczyk W, Budach V, Koehler C, Marnitz S. Optimizing image guidance frequency and implications on margins for gynecologic malignancies. Radiation oncology. 2013;8(1):110.</p>
<p>31.&nbsp;Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, et al. [S3-guideline exocrine pancreatic cancer]. Zeitschrift fur Gastroenterologie. 2013;51(12):1395-440.</p>
<p>32.&nbsp;Meinke MC, Syring F, Schanzer S, Haag SF, Graf R, Loch M, et al. Radical protection by differently composed creams in the UV/VIS and IR spectral ranges. Photochemistry and photobiology. 2013;89(5):1079-84.</p>
<p>33.&nbsp;Maurer MH, Synowitz M, Badakshi H, Lohkamp LN, Wustefeld J, Schafer ML, et al. Glioblastoma multiforme versus solitary supratentorial brain metastasis: differentiation based on morphology and magnetic resonance signal characteristics. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2013;185(3):235-40.</p>
<p>34.&nbsp;Matuschek C, Bolke E, Belka C, Ganswindt U, Henke M, Stegmaier P, et al. Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2013;189(8):625-31.</p>
<p>35.&nbsp;Marnitz S, Kohler C, Budach V, Neumann O, Kluge A, Wlodarczyk W, et al. Robotic radiosurgery: emulating brachytherapy in patients with locally advanced cervical carcinoma. Technique, feasibility and acute toxicity. Radiation oncology. 2013;8(1):109.</p>
<p>36.&nbsp;Mangler M, Zech N, Schneider A, Kohler C, Marnitz S. Aspects of Therapy for Cervical Cancer in Germany 2012 - Results from a Survey of German Gynaecological Hospitals. Geburtshilfe und Frauenheilkunde. 2013;73(3):227-38.</p>
<p>37.&nbsp;Koustenis E, Pfitzer C, Balcerek M, Reinmuth S, Zynda A, Stromberger C, et al. Impact of cranial irradiation and brain tumor location on fertility: a survey. Klinische Padiatrie. 2013;225(6):320-4.</p>
<p>38.&nbsp;Kaul D, Bonhomme O, Schwabe P, Gebauer B, Streitparth F. Osteoid Osteoma with a Multicentric Nidus: Interstitial Laser Ablation under MRI Guidance. Case reports in orthopedics. 2013;2013:254825.</p>
<p>39.&nbsp;Holler U, Schubert T, Budach V, Trefzer U, Beyer M. Blisters - an unusual effect during radiotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2013;189(11):977-9.</p>
<p>40.&nbsp;Hoff P, Rakow A, Gaber T, Hahne M, Senturk U, Strehl C, et al. Preoperative irradiation for the prevention of heterotopic ossification induces local inflammation in humans. Bone. 2013;55(1):93-101.</p>
<p>41.&nbsp;Helmberger T, Marti-Bonmati L, Pereira P, Gillams A, Martinez J, Lammer J, et al. Radiologists' leading position in image-guided therapy. Insights into imaging. 2013;4(1):1-7.</p>
<p>42.&nbsp;Gruen A, Ebell W, Wlodarczyk W, Neumann O, Kuehl JS, Stromberger C, et al. Total Body Irradiation (TBI) using helical tomotherapy in children and young adults undergoing stem cell transplantation. Radiation oncology. 2013;8(1):92.</p>
<p>43.&nbsp;Graf R, Nyuyki F, Steffen IG, Michel R, Fahdt D, Wust P, et al. Contribution of 68Ga-DOTATOC PET/<abbr title="Computertomographie">CT</abbr> to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy. International journal of radiation oncology, biology, physics. 2013;85(1):68-73.</p>
<p>44.&nbsp;Geisel D, Collettini F, Denecke T, Grieser C, Florcken A, Wust P, et al. Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (<abbr title="Computertomographie">CT</abbr>-HDRBT): a case series. World journal of urology. 2013;31(6):1525-30.</p>
<p>45.&nbsp;Dorenkamp M, Stromberger C, von Heymann C, Haverkamp W, Wust P, Roser M. [Radiation therapy in patients with cardiac pacemakers or implantable cardioverter defibrillators. Interdisciplinary safety recommendations]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2013;189(1):5-17.</p>
<p>46.&nbsp;Collettini F, Singh A, Schnapauff D, Powerski MJ, Denecke T, Wust P, et al. Computed-tomography-guided high-dose-rate brachytherapy (<abbr title="Computertomographie">CT</abbr>-HDRBT) ablation of metastases adjacent to the liver hilum. European journal of radiology. 2013;82(10):e509-14.</p>
<p>47.&nbsp;Collettini F, Schippers AC, Schnapauff D, Denecke T, Hamm B, Riess H, et al. Percutaneous ablation of lymph node metastases using <abbr title="Computertomographie">CT</abbr>-guided high-dose-rate brachytherapy. The British journal of radiology. 2013;86(1027):20130088.</p>
<p>48.&nbsp;Clivio A, Kluge A, Cozzi L, Kohler C, Neumann O, Vanetti E, et al. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma. International journal of radiation oncology, biology, physics. 2013;87(5):897-903.</p>
<p>49.&nbsp;Badakhshi H, Wust P, Budach V, Graf R. Image-guided radiotherapy with implanted markers and kilovoltage imaging and 6-dimensional position corrections for intrafractional motion of the prostate. Anticancer research. 2013;33(9):4117-21.</p>
<p>50.&nbsp;Badakhshi H, Kaul D, Wust P, Wiener E, Budach V, Graf R. Image-guided stereotactic radiosurgery for cranial lesions: large margins compensate for reduced image guidance frequency. Anticancer research. 2013;33(10):4639-43.</p>
<p>51.&nbsp;Badakhshi H, Kaul D, Nadobny J, Wille B, Sehouli J, Budach V. Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy. The British journal of radiology. 2013;86(1032):20130515.</p>
<p>52.&nbsp;Badakhshi H, Grun A, Stromberger C, Budach V, Boehmer D. Oligometastases: the new paradigm and options for radiotherapy. A critical review. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2013;189(5):357-62.</p>
<p>53.&nbsp;Badakhshi H, Gruen A, Sehouli J, Budach V, Boehmer D. The impact of patient compliance with adjuvant radiotherapy: a comprehensive cohort study. Cancer medicine. 2013;2(5):712-7.</p>
<p>54.&nbsp;Badakhshi H, Gruen A, Graf R, Boehmer D, Budach V. Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2013.</p>
<p>55.&nbsp;Badakhshi H, Budach V, Wust P, Graf R. Anal carcinoma: surgery does not influence prognosis when performed prior to concurrent radiochemotherapy. Anticancer research. 2013;33(9):4111-5.</p>
<p>56.&nbsp;Badakhshi H, Barelkowski T, Wust P, Budach V, Boehmer D, Graf R. Intrafraction variations in linac-based image-guided radiosurgery of intracranial lesions. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 2013;17(7):664-7.</p>
<p>57.&nbsp;Winzer KJ, Gruber C, Badakhshi H, Hinkelbein M, Denkert C. [Compliance of patients concerning recommended radiotherapy in breast cancer : Association with recurrence, age, and hormonal therapy]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2012;188(9):788-94.</p>
<p>58.&nbsp;Tinhofer I, Hristozova T, Stromberger C, Keilhoiz U, Budach V. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. International journal of radiation oncology, biology, physics. 2012;83(5):e685-90.</p>
<p>59.&nbsp;Sehouli J, Runnebaum IB, Fotopoulou C, Blohmer U, Belau A, Leber H, et al. A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2012;23(9):2259-64.</p>
<p>60.&nbsp;Schnapauff D, Denecke T, Grieser C, Collettini F, Seehofer D, Sinn M, et al. Computed tomography-guided interstitial HDR brachytherapy (<abbr title="Computertomographie">CT</abbr>-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma. Cardiovascular and interventional radiology. 2012;35(3):581-7.</p>
<p>61.&nbsp;Naether A, Foesel BU, Naegele V, Wust PK, Weinert J, Bonkowski M, et al. Environmental factors affect Acidobacterial communities below the subgroup level in grassland and forest soils. Applied and environmental microbiology. 2012;78(20):7398-406.</p>
<p>62.&nbsp;Marnitz S, Kohler C, Burova E, Wlodarczyk W, Jahn U, Grun A, et al. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity. International journal of radiation oncology, biology, physics. 2012;82(2):e137-43.</p>
<p>63.&nbsp;Marnitz S, Kohler C, Affonso RJ, Schneider A, Chiantera V, Tsounoda A, et al. Validity of laparoscopic staging to avoid adjuvant chemoradiation following radical surgery in patients with early cervical cancer. Oncology. 2012;83(6):346-53.</p>
<p>64.&nbsp;Marnitz S, Kohler C. Current therapy of patients with endometrial carcinoma. A critical review. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2012;188(1):12-20.</p>
<p>65.&nbsp;Marnitz S, Budach V, Weisser F, Burova E, Gebauer B, Vercellino FG, et al. Rectum separation in patients with cervical cancer for treatment planning in primary chemo-radiation. Radiation oncology. 2012;7:109.</p>
<p>66.&nbsp;Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J, et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nature neuroscience. 2012;15(6):827-35.</p>
<p>67.&nbsp;Koehler C, Gottschalk E, Chiantera V, Marnitz S, Hasenbein K, Schneider A. From laparoscopic assisted radical vaginal hysterectomy to vaginal assisted laparoscopic radical hysterectomy. BJOG : an international journal of obstetrics and gynaecology. 2012;119(2):254-62.</p>
<p>68.&nbsp;Kaul D, Habbel P, Derkow K, Kruger C, Franzoni E, Wulczyn FG, et al. Expression of Toll-like receptors in the developing brain. PloS one. 2012;7(5):e37767.</p>
<p>69.&nbsp;Kamphues C, Seehofer D, Collettini F, Bahra M, Neuhaus P, Wust P, et al. Preliminary experience with <abbr title="Computertomographie">CT</abbr>-guided high-dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2012;14(12):791-7.</p>
<p>70.&nbsp;Jiang P, Marnitz S. [Adjuvant radiochemotherapy of uterine carcinosarcoma in need of optimization]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2012;188(9):843-6.</p>
<p>71.&nbsp;Hristozova T, Konschak R, Budach V, Tinhofer I. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers. Cytometry Part A : the journal of the International Society for Analytical Cytology. 2012;81(6):489-95.</p>
<p>72.&nbsp;Graf R, Plotkin M, Steffen IG, Wurm R, Wust P, Brenner W, et al. Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series. Head &amp; face medicine. 2012;8:1.</p>
<p>73.&nbsp;Graf R, Plotkin M, Nyuyki F, Wust P, Wurm R, Budach V, et al. Contribution of (18)F-Fluoro-ethyl-tyrosine Positron Emission Tomography to Target Volume Delineation in Stereotactic Radiotherapy of Malignant Cranial Base Tumours: First Clinical Experience. International journal of molecular imaging. 2012;2012:412585.</p>
<p>74.&nbsp;Graf R, Boehmer D, Nadobny J, Budach V, Wust P. Appropriate patient instructions can reduce prostate motion. Radiation oncology. 2012;7:125.</p>
<p>75.&nbsp;Graf R, Boehmer D, Budach V, Wust P. Interfraction rotation of the prostate as evaluated by kilovoltage X-ray fiducial marker imaging in intensity-modulated radiotherapy of localized prostate cancer. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2012;37(4):396-400.</p>
<p>76.&nbsp;Geisel D, Denecke T, Collettini F, Grieser C, Wust P, Thuss-Patience P, et al. Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (<abbr title="Computertomographie">CT</abbr>-HDRBT). Anticancer research. 2012;32(12):5453-8.</p>
<p>77.&nbsp;Collettini F, Schnapauff D, Poellinger A, Denecke T, Schott E, Berg T, et al. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (<abbr title="Computertomographie">CT</abbr>-HDRBT) ablation of large (5-7 cm) and very large (&gt;7 cm) tumours. European radiology. 2012;22(5):1101-9.</p>
<p>78.&nbsp;Collettini F, Schnapauff D, Poellinger A, Denecke T, Banzer J, Golenia MJ, et al. [Percutaneous <abbr title="Computertomographie">CT</abbr>-guided high-dose brachytherapy (<abbr title="Computertomographie">CT</abbr>-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2012;184(4):316-23.</p>
<p>79.&nbsp;Collettini F, Golenia M, Schnapauff D, Poellinger A, Denecke T, Wust P, et al. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions. Journal of vascular and interventional radiology : JVIR. 2012;23(5):618-26.</p>
<p>80.&nbsp;Wust PK, Horn MA, Drake HL. Clostridiaceae and Enterobacteriaceae as active fermenters in earthworm gut content. The ISME journal. 2011;5(1):92-106.</p>
<p>81.&nbsp;Wieners G, Mohnike K, Peters N, Bischoff J, Kleine-Tebbe A, Seidensticker R, et al. Treatment of hepatic metastases of breast cancer with <abbr title="Computertomographie">CT</abbr>-guided interstitial brachytherapy - a phase II-study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2011;100(2):314-9.</p>
<p>82.&nbsp;Tinhofer I, Klinghammer K, Weichert W, Knodler M, Stenzinger A, Gauler T, et al. Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011;17(15):5197-204.</p>
<p>83.&nbsp;Seidensticker M, Seidensticker R, Mohnike K, Wybranski C, Kalinski T, Luess S, et al. Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes. Radiation oncology. 2011;6:40.</p>
<p>84.&nbsp;Schultz BJ, Wust P, Ludemann L, Jost G, Pietsch H. Monte Carlo simulation of contrast-enhanced whole brain radiotherapy on a <abbr title="Computertomographie">CT</abbr> scanner. Medical physics. 2011;38(8):4672-80.</p>
<p>85.&nbsp;Schmidt O, Wust PK, Hellmuth S, Borst K, Horn MA, Drake HL. Novel [NiFe]- and [FeFe]-hydrogenase gene transcripts indicative of active facultative aerobes and obligate anaerobes in earthworm gut contents. Applied and environmental microbiology. 2011;77(17):5842-50.</p>
<p>86.&nbsp;Ricke J, Wust P. Computed tomography-guided brachytherapy for liver cancer. Seminars in radiation oncology. 2011;21(4):287-93.</p>
<p>87.&nbsp;Marnitz S, Lukarski D, Kohler C, Wlodarczyk W, Ebert A, Budach V, et al. Helical tomotherapy versus conventional intensity-modulated radiation therapy for primary chemoradiation in cervical cancer patients: an intraindividual comparison. International journal of radiation oncology, biology, physics. 2011;81(2):424-30.</p>
<p>88.&nbsp;Marnitz S, Kettritz R, Kahl A, Lehenbauer-Dehm S, Forster L, Budach V, et al. Simultaneous chemoradiation with cisplatin in a patient with recurrent cervical cancer undergoing hemodialysis: analysis of cisplatin concentrations in serum and dialysate and therapy-related acute toxicity. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2011;187(12):831-4.</p>
<p>89.&nbsp;Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. Journal of neuro-oncology. 2011;103(2):317-24.</p>
<p>90.&nbsp;Ludemann L, Wybranski C, Seidensticker M, Mohnike K, Kropf S, Wust P, et al. In vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction 192Ir high-dose-rate brachytherapy. Radiation oncology. 2011;6:107.</p>
<p>91.&nbsp;Lanowska M, Kohler C, Oppelt P, Schmittel A, Gottschalk E, Hasenbein K, et al. Addressing concerns about cisplatin application during pregnancy. Journal of perinatal medicine. 2011;39(3):279-85.</p>
<p>92.&nbsp;Hristozova T, Konschak R, Stromberger C, Fusi A, Liu Z, Weichert W, et al. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2011;22(8):1878-85.</p>
<p>93.&nbsp;Holz C, Niehr F, Boyko M, Hristozova T, Distel L, Budach V, et al. Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2011;101(1):158-64.</p>
<p>94.&nbsp;Gruen A, Musik T, Kohler C, Fuller J, Wendt T, Stromberger C, et al. Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidity. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2011;187(6):344-9.</p>
<p>95.&nbsp;Gottschalk E, Lanowska M, Chiantera V, Marnitz S, Schneider A, Brink-Spalink V, et al. Vaginal-assisted laparoscopic radical hysterectomy: rationale, technique, results. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons. 2011;15(4):451-9.</p>
<p>96.&nbsp;Collettini F, Poellinger A, Schnapauff D, Denecke T, Wust P, Braicu IE, et al. <abbr title="Computertomographie">CT</abbr>-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience. Anticancer research. 2011;31(8):2597-602.</p>
<p>97.&nbsp;Brinkhaus G, Wust P, Gebauer B. [Multimodal interventional therapy of a large renal cell carcinoma in a patient with high anesthesia risk - a case report]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2011;183(3):286-8.</p>
<p>98.&nbsp;Blohmer JU, Paepke S, Sehouli J, Boehmer D, Kolben M, Wurschmidt F, et al. Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(28):3791-7.</p>
<p>99.&nbsp;Baumann M, Herrmann T, Koch R, Matthiessen W, Appold S, Wahlers B, et al. Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC). Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2011;100(1):76-85.</p>
<p>100.&nbsp;Weichert W, Koch M, Schmidt B, Krull M, Badakhshi H, Neudecker J, et al. Mature mediastinal teratoma with subtotal unidirectional pancreatic differentiation. Pathology, research and practice. 2010;206(5):346-8.</p>
<p>101.&nbsp;Van Laethem JL, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28(29):4450-6.</p>
<p>102.&nbsp;Stromberger C, Kom Y, Kawgan-Kagan M, Mensing T, Jahn U, Schneider A, et al. Intensity-modulated radiotherapy in patients with cervical cancer. An intra-individual comparison of prone and supine positioning. Radiation oncology. 2010;5:63.</p>
<p>103.&nbsp;Stock M, Dorr W, Stromberger C, Mock U, Koizar S, Potter R, et al. Investigations on parotid gland recovery after IMRT in head and neck tumor patients. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2010;186(12):665-71.</p>
<p>104.&nbsp;Steffen IG, Wust P, Ruhl R, Grieser C, Schnapauff D, Ludemann L, et al. Value of combined PET/<abbr title="Computertomographie">CT</abbr> for radiation planning in <abbr title="Computertomographie">CT</abbr>-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases. International journal of radiation oncology, biology, physics. 2010;77(4):1178-85.</p>
<p>105.&nbsp;Sinn B, Tallen G, Schroeder G, Grassl B, Schulze J, Budach V, et al. Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylation. Molecular cancer therapeutics. 2010;9(2):480-8.</p>
<p>106.&nbsp;Sinn B, Schulze J, Schroeder G, Konschak R, Freyer D, Budach V, et al. Pifithrin-alpha as a potential cytoprotective agent in radiotherapy: protection of normal tissue without decreasing therapeutic efficacy in glioma cells. Radiation research. 2010;174(5):601-10.</p>
<p>107.&nbsp;Seidensticker M, Wust P, Ruhl R, Mohnike K, Pech M, Wieners G, et al. Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiation oncology. 2010;5:24.</p>
<p>108.&nbsp;Sehouli J, Pietzner K, Harter P, Munstedt K, Mahner S, Hasenburg A, et al. Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2010;21(11):2201-5.</p>
<p>109.&nbsp;Ruhl R, Ludemann L, Czarnecka A, Streitparth F, Seidensticker M, Mohnike K, et al. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases. Radiation oncology. 2010;5:44.</p>
<p>110.&nbsp;Ricke J, Mohnike K, Pech M, Seidensticker M, Ruhl R, Wieners G, et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. International journal of radiation oncology, biology, physics. 2010;78(2):479-85.</p>
<p>111.&nbsp;Ranneberg M, Weiser M, Weihrauch M, Budach V, Gellermann J, Wust P. Regularized antenna profile adaptation in online hyperthermia treatment. Medical physics. 2010;37(10):5382-94.</p>
<p>112.&nbsp;Oliveira-Ferreira AI, Milakara D, Alam M, Jorks D, Major S, Hartings JA, et al. Experimental and preliminary clinical evidence of an ischemic zone with prolonged negative DC shifts surrounded by a normally perfused tissue belt with persistent electrocorticographic depression. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2010;30(8):1504-19.</p>
<p>113.&nbsp;Nyuyki F, Plotkin M, Graf R, Michel R, Steffen I, Denecke T, et al. Potential impact of (68)Ga-DOTATOC PET/<abbr title="Computertomographie">CT</abbr> on stereotactic radiotherapy planning of meningiomas. European journal of nuclear medicine and molecular imaging. 2010;37(2):310-8.</p>
<p>114.&nbsp;Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R, et al. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. International journal of radiation oncology, biology, physics. 2010;78(1):172-9.</p>
<p>115.&nbsp;Merz H, Marnitz S, Erbersdobler A, Goektas O. Schmincke's Tumor, Carcinoma of the Base of the Tongue c T1-2, cN2c M0 - A Case Report. Case reports in oncology. 2010;3(1):77-82.</p>
<p>116.&nbsp;Marnitz S, Stromberger C, Kawgan-Kagan M, Wlodarczyk W, Jahn U, Schneider A, et al. Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2010;186(10):572-9.</p>
<p>117.&nbsp;Marnitz S, Kohler C, Oppelt P, Schmittel A, Favero G, Hasenbein K, et al. Cisplatin application in pregnancy: first in vivo analysis of 7 patients. Oncology. 2010;79(1-2):72-7.</p>
<p>118.&nbsp;Ludemann L, Wlodarczyk W, Nadobny J, Weihrauch M, Gellermann J, Wust P. Non-invasive magnetic resonance thermography during regional hyperthermia. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(3):273-82.</p>
<p>119.&nbsp;Lanowska M, Vasiljeva J, Chiantera V, Marnitz S, Schneider A, Rudolph B, et al. Implication of the examining pathologist to meet the oncologic standard of lymph node count after laparoscopic lymphadenectomy. Oncology. 2010;79(3-4):161-7.</p>
<p>120.&nbsp;Klinghammer K, Knodler M, Schmittel A, Budach V, Keilholz U, Tinhofer I. Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010;16(1):304-10.</p>
<p>121.&nbsp;Johannsen M, Thiesen B, Wust P, Jordan A. Magnetic nanoparticle hyperthermia for prostate cancer. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(8):790-5.</p>
<p>122.&nbsp;Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. The lancet oncology. 2010;11(6):561-70.</p>
<p>123.&nbsp;Halkett G, Aoun S, Hayne D, Lund JA, Gruen A, Villa J, et al. EORTC radiation proctitis-specific quality of life module - pretesting in four European countries. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2010;97(2):294-300.</p>
<p>124.&nbsp;Graf R, Boehmer D, Budach V, Wust P. Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2010;186(10):544-50.</p>
<p>125.&nbsp;Fotopoulou C, Cho CH, Kraetschell R, Gellermann J, Wust P, Lichtenegger W, et al. Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(2):118-26.</p>
<p>126.&nbsp;Favero G, Lanowska M, Schneider A, Marnitz S, Kohler C. Laparoscopic pelvic lymphadenectomy in a patient with cervical cancer stage Ib1 complicated by a twin pregnancy. Journal of minimally invasive gynecology. 2010;17(1):118-20.</p>
<p>127.&nbsp;Favero G, Lanowska M, Schneider A, Marnitz S, Kohler C. Laparoscopic approach for correction of chylous fistula after pelvic and paraaortic lymphadenectomy. Journal of minimally invasive gynecology. 2010;17(2):262-4.</p>
<p>128.&nbsp;Favero G, Chiantera V, Oleszczuk A, Gallotta V, Hertel H, Herrmann J, et al. Invasive cervical cancer during pregnancy: laparoscopic nodal evaluation before oncologic treatment delay. Gynecologic oncology. 2010;118(2):123-7.</p>
<p>129.&nbsp;Deja M, Ahlers O, Macguill M, Wust P, Hildebrandt B, Riess H, et al. Changes in hepatic blood flow during whole body hyperthermia. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(2):95-100.</p>
<p>130.&nbsp;Cho CH, Sreenivasa G, Plotkin M, Pietsch H, Wust P, Ludemann L. Tumour perfusion assessment during regional hyperthermia treatment: comparison of temperature probe measurement with H(2)(15)O-PET perfusion. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(4):404-11.</p>
<p>131.&nbsp;Budach V. TPF sequential therapy: when and for whom? The oncologist. 2010;15 Suppl 3:13-8.</p>
<p>132.&nbsp;Wybranski C, Seidensticker M, Mohnike K, Kropf S, Wust P, Ricke J, et al. In vivo assessment of dose volume and dose gradient effects on the tolerance dose of small liver volumes after single-fraction high-dose-rate 192Ir irradiation. Radiation research. 2009;172(5):598-606.</p>
<p>133.&nbsp;Wust PK, Horn MA, Henderson G, Janssen PH, Rehm BH, Drake HL. Gut-associated denitrification and in vivo emission of nitrous oxide by the earthworm families megascolecidae and lumbricidae in new zealand. Applied and environmental microbiology. 2009;75(11):3430-6.</p>
<p>134.&nbsp;Wust PK, Horn MA, Drake HL. In situ hydrogen and nitrous oxide as indicators of concomitant fermentation and denitrification in the alimentary canal of the earthworm Lumbricus terrestris. Applied and environmental microbiology. 2009;75(7):1852-9.</p>
<p>135.&nbsp;Wust PK, Horn MA, Drake HL. Trophic links between fermenters and methanogens in a moderately acidic fen soil. Environmental microbiology. 2009;11(6):1395-409.</p>
<p>136.&nbsp;Wust P, Weihrauch M. Hyperthermia classic commentary: 'Simulation studies promote technological development of radiofrequency phased array hyperthermia' by Peter Wust et al., International Journal of Hyperthermia 1996;12:477-494. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2009;25(7):529-32.</p>
<p>137.&nbsp;Wust P, Seebass M, Nadobny J, Deuflhard P, Monich G, Felix R. Simulation studies promote technological development of radiofrequency phased array hyperthermia. 1996. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2009;25(7):517-28.</p>
<p>138.&nbsp;Woitzik J, Lassel E, Hecht N, Schneider UC, Schroeck H, Vajkoczy P, et al. Ischemia independent lesion evolution during focal stroke in rats. Experimental neurology. 2009;218(1):41-6.</p>
<p>139.&nbsp;Wieners G, Pech M, Hildebrandt B, Peters N, Nicolaou A, Mohnike K, et al. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal &quot;liver-only&quot; metastases: hepatic interstitial brachytherapy plus regional chemotherapy. Cardiovascular and interventional radiology. 2009;32(5):937-45.</p>
<p>140.&nbsp;Welz H, Pottgen C, Abu Jawad J, Wierlemann A, Wittig A, Stuben G, et al. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series. Oncology. 2009;76(6):405-12.</p>
<p>141.&nbsp;Siegel R, Burock S, Wernecke KD, Kretzschmar A, Dietel M, Loy V, et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC cancer. 2009;9:50.</p>
<p>142.&nbsp;Pietzner K, Oskay-Oezcelik G, El Khalfaoui K, Boehmer D, Lichtenegger W, Sehouli J. Brain metastases from epithelial ovarian cancer: overview and optimal management. Anticancer research. 2009;29(7):2793-8.</p>
<p>143.&nbsp;Ochsenreither S, Marnitz-Schultze S, Schneider A, Koehler C, Daum S, Loddenkemper C, et al. Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charite. Anticancer research. 2009;29(8):3411-5.</p>
<p>144.&nbsp;Marnitz S, Schmittel A, Bolbrinker J, Schmidt FP, Fons G, Kalache K, et al. The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum. Fertility and sterility. 2009;92(5):1748 e1-4.</p>
<p>145.&nbsp;Marnitz S, Dowdy S, Lanowska M, Schneider A, Podratz K, Kohler C. Exenterations 60 years after first description: results of a survey among US and German Gynecologic Oncology Centers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2009;19(5):974-7.</p>
<p>146.&nbsp;Ludemann L, Warmuth C, Plotkin M, Forschler A, Gutberlet M, Wust P, et al. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. European journal of radiology. 2009;70(3):465-74.</p>
<p>147.&nbsp;Ludemann L, Sreenivasa G, Amthauer H, Michel R, Gellermann J, Wust P. Use of H(2) (15)O-PET for investigating perfusion changes in pelvic tumors due to regional hyperthermia. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2009;25(4):299-308.</p>
<p>148.&nbsp;Jost G, Mensing T, Golfier S, Lawaczeck R, Pietsch H, Hutter J, et al. Photoelectric-enhanced radiation therapy with quasi-monochromatic computed tomography. Medical physics. 2009;36(6):2107-17.</p>
<p>149.&nbsp;Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. 1993. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2009;25(7):499-511.</p>
<p>150.&nbsp;Gruen A. Childhood and the loss of contact with reality: the prospects for democracy. The Journal of psychohistory. 2009;36(3):270-83.</p>
<p>151.&nbsp;Gruen A. The implications of denying fear and anxiety and idealizing victimizers. The Journal of psychohistory. 2009;37(1):59-66.</p>
<p>152.&nbsp;Graf R, Wust P, Budach V, Boehmer D. Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy. Radiation oncology. 2009;4:13.</p>
<p>153.&nbsp;Drake HL, Horn MA, Wust PK. Intermediary ecosystem metabolism as a main driver of methanogenesis in acidic wetland soil. Environmental microbiology reports. 2009;1(5):307-18.</p>
<p>154.&nbsp;Canters RA, Wust P, Bakker JF, Van Rhoon GC. A literature survey on indicators for characterisation and optimisation of SAR distributions in deep hyperthermia, a plea for standardisation. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2009;25(7):593-608.</p>
<p>155.&nbsp;Bremke M, Barth PJ, Sesterhenn AM, Budach V, Engenhart-Cabillic R, Werner JA. Prospective study on neck dissection after primary chemoradiation therapy in stage IV pharyngeal cancer. Anticancer research. 2009;29(7):2645-53.</p>
<p>156.&nbsp;Wust P, Postrach J, Kahmann F, Henkel T, Graf R, Cho CH, et al. Postimplantation analysis enables improvement of dose-volume histograms and reduction of toxicity for permanent seed implantation. International journal of radiation oncology, biology, physics. 2008;71(1):28-35.</p>
<p>157.&nbsp;Wurm RE, Erbel S, Schwenkert I, Gum F, Agaoglu D, Schild R, et al. Novalis frameless image-guided noninvasive radiosurgery: initial experience. Neurosurgery. 2008;62(5 Suppl):A11-7; discussion A7-8.</p>
<p>158.&nbsp;Willimsky G, Czeh M, Loddenkemper C, Gellermann J, Schmidt K, Wust P, et al. Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. The Journal of experimental medicine. 2008;205(7):1687-700.</p>
<p>159.&nbsp;Vogt M, Kohler C, Marnitz S, Cho CH, Lanowska M, Schneider A, et al. Vaginal herniation after secondary laparoscopic assisted vaginal hysterectomy following primary radiochemotherapy for stage IIIA cervical cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2008;88(2):285-6.</p>
<p>160.&nbsp;Ruckert JC, Ismail M, Swierzy M, Braumann C, Badakhshi H, Rogalla P, et al. [Minimally invasive thymus surgery]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2008;79(1):18, 20-5.</p>
<p>161.&nbsp;Rodel C, Hohler T, Sauer R, Siewczynski R, Flentje M, Budach V, et al. [Multimodality treatment for colorectal cancer]. Onkologie. 2008;31 Suppl 5:24-8.</p>
<p>162.&nbsp;Peters N, Wieners G, Pech M, Hengst S, Ruhl R, Streitparth F, et al. <abbr title="Computertomographie">CT</abbr>-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2008;184(6):296-301.</p>
<p>163.&nbsp;Pech M, Wieners G, Kryza R, Dudeck O, Seidensticker M, Mohnike K, et al. <abbr title="Computertomographie">CT</abbr>-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2008;184(6):302-6.</p>
<p>164.&nbsp;Pech M, Ricke J, Seidensticker M, Staskiewicz G, Wieners G, Mohnike K, et al. Assessment of the tolerance dose of the hepatic reticulo-endothelial system (RES) after single fraction HDR-irradiation: an in-vivo study employing SSPIO. International journal of radiation biology. 2008;84(10):830-7.</p>
<p>165.&nbsp;Pech M, Mohnike K, Wieners G, Bialek E, Dudeck O, Seidensticker M, et al. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing <abbr title="Computertomographie">CT</abbr>- or MRI-based treatment planning. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2008;184(5):256-61.</p>
<p>166.&nbsp;Oehme L, Dorr W, Wust P, Kotzerke J. [Influence of time-dose-relationships in therapeutic nuclear medicine applications on biological effectiveness of irradiation: consequences for dosimetry]. Nuklearmedizin Nuclear medicine. 2008;47(5):205-9.</p>
<p>167.&nbsp;Ludemann L, Wust P, Gellermann J. Perfusion measurement using DCE-MRI: implications for hyperthermia. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2008;24(1):91-6.</p>
<p>168.&nbsp;Kasprowicz NS, Fotopoulou C, Oskay-Ozcelik G, El KK, Boehmer D, Sehouli J. Brain metastases in relapsed epithelial ovarian cancer after chemotherapy with pegylated liposomal doxorubicin. Anticancer research. 2008;28(3B):1943-6.</p>
<p>169.&nbsp;Kaiser A, Budach V. Neoadjuvant and adjuvant strategies for chemoradiation. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2008;177:65-77.</p>
<p>170.&nbsp;Jost G, Golfier S, Lawaczeck R, Weinmann HJ, Gerlach M, Cibik L, et al. Imaging-therapy computed tomography with quasi-monochromatic X-rays. European journal of radiology. 2008;68(3 Suppl):S63-8.</p>
<p>171.&nbsp;Johannsen M, Jordan A, Wust P, Loening SA. Re: Lyndon Gommersall, Iqbal S. Shergill, Hashim U. Ahmed et al. Nanotechnology and its relevance to the urologist. Eur Urol 2007;52:368-75. European urology. 2008;53(4):860.</p>
<p>172.&nbsp;Gellermann J, Faehling H, Mielec M, Cho CH, Budach V, Wust P. Image artifacts during <abbr title="Magnetresonanztomograph">MRT</abbr> hybrid hyperthermia--causes and elimination. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2008;24(4):327-35.</p>
<p>173.&nbsp;Cho C, Wust P, Hildebrandt B, Issels RD, Sehouli J, Kerner T, et al. Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2008;24(5):399-408.</p>
<p>174.&nbsp;Chekerov R, Denkert C, Boehmer D, Suesse A, Widing A, Ruhmland B, et al. Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2008;18(1):1-7.</p>
<p>175.&nbsp;Boehmer D. Combined radiotherapy and hormonal therapy in the treatment of prostate cancer. Frontiers of radiation therapy and oncology. 2008;41:26-31.</p>
<p>176.&nbsp;Bischoff A, Marnitz S, Kohler C, Kurzeja R, Morawietz L, Schneider A, et al. Complete remission after neoadjuvant chemoradiation in a stage IV vulvar cancer patient. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2008;184(8):421-5.</p>
<p>177.&nbsp;Badakhshi H, Marnitz S, Scherer H, Budach V, Haisch A. [Adenoid cystic carcinoma of the oropharynx. Brachytherapy for the treatment of local recurrences]. Hno. 2008;56(3):328-31.</p>
<p>178.&nbsp;Wust P, Nadobny J, Szimtenings M, Stetter E, Gellermann J. Implications of clinical RF hyperthermia on protection limits in the RF range. Health physics. 2007;92(6):565-73.</p>
<p>179.&nbsp;Wust P. [They should make thermotherapy more effective. Hot nanoparticles against cancer]. MMW Fortschritte der Medizin. 2007;149(33-34):16.</p>
<p>180.&nbsp;Weihrauch M, Wust P, Weiser M, Nadobny J, Eisenhardt S, Budach V, et al. Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system. Medical physics. 2007;34(12):4717-25.</p>
<p>181.&nbsp;Stein ME, Boehmer D, Kuten A. Radiation therapy in prostate cancer. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2007;175:179-99.</p>
<p>182.&nbsp;Pottgen C, Eberhardt W, Grannass A, Korfee S, Stuben G, Teschler H, et al. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(31):4987-92.</p>
<p>183.&nbsp;Poortmans P, Bossi A, Vandeputte K, Bosset M, Miralbell R, Maingon P, et al. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2007;84(2):121-7.</p>
<p>184.&nbsp;Nadobny J, Szimtenings M, Diehl D, Stetter E, Brinker G, Wust P. Evaluation of MR-induced hot spots for different temporal SAR modes using a time-dependent finite difference method with explicit temperature gradient treatment. IEEE transactions on bio-medical engineering. 2007;54(10):1837-50.</p>
<p>185.&nbsp;Musat E, Poortmans P, Van den Bogaert W, Struikmans H, Fourquet A, Bartelink H, et al. Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes. European journal of cancer. 2007;43(4):718-24.</p>
<p>186.&nbsp;Marnitz S, Kohler C, Roth C, Fuller J, Bischoff A, Wendt T, et al. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2007;183(9):473-8.</p>
<p>187.&nbsp;Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. Journal of neuro-oncology. 2007;81(1):53-60.</p>
<p>188.&nbsp;Ludemann L, Forschler A, Wust P, Zimmer C. Quantification of fMRI BOLD signal and volume applied to the somatosensory cortex. Zeitschrift fur medizinische Physik. 2007;17(2):108-17.</p>
<p>189.&nbsp;Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, et al. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. Journal of neuroimmunology. 2007;190(1-2):28-33.</p>
<p>190.&nbsp;Kuczer D, Feussner A, Wurm R, Wust P, Michel R, Stockhammer F, et al. 123I-IMT SPECT for evaluation of the response to radiation therapy in high grade gliomas: a feasibility study. The British journal of radiology. 2007;80(952):274-8.</p>
<p>191.&nbsp;Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldofner N, et al. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. European urology. 2007;52(6):1653-61.</p>
<p>192.&nbsp;Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldofner N, Scholz R, et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2007;23(3):315-23.</p>
<p>193.&nbsp;Johannsen M, Gneveckow U, Taymoorian K, Cho CH, Thiesen B, Scholz R, et al. [Thermal therapy of prostate cancer using magnetic nanoparticles]. Actas urologicas espanolas. 2007;31(6):660-7.</p>
<p>194.&nbsp;Hildebrandt B, Wust P. The biologic rationale of hyperthermia. Cancer treatment and research. 2007;134:171-84.</p>
<p>195.&nbsp;Hildebrandt B, Wust P. Interactions between hyperthermia and cytotoxic drugs. Cancer treatment and research. 2007;134:185-93.</p>
<p>196.&nbsp;Gellermann J, Goke J, Figiel R, Weihrauch M, Cho CH, Budach V, et al. Simulation of different applicator positions for treatment of a presacral tumour. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2007;23(1):37-47.</p>
<p>197.&nbsp;Dieing A, Ahlers O, Hildebrandt B, Kerner T, Tamm I, Possinger K, et al. The effect of induced hyperthermia on the immune system. Progress in brain research. 2007;162:137-52.</p>
<p>198.&nbsp;Wust P, Gneveckow U, Johannsen M, Bohmer D, Henkel T, Kahmann F, et al. Magnetic nanoparticles for interstitial thermotherapy--feasibility, tolerance and achieved temperatures. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2006;22(8):673-85.</p>
<p>199.&nbsp;Wust P, Cho CH, Hildebrandt B, Gellermann J. Thermal monitoring: invasive, minimal-invasive and non-invasive approaches. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2006;22(3):255-62.</p>
<p>200.&nbsp;Wurm RE, Gum F, Erbel S, Schlenger L, Scheffler D, Agaoglu D, et al. Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta oncologica. 2006;45(7):881-9.</p>
<p>201.&nbsp;Streitparth F, Pech M, Bohmig M, Ruehl R, Peters N, Wieners G, et al. In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. International journal of radiation oncology, biology, physics. 2006;65(5):1479-86.</p>
<p>202.&nbsp;Sreenivasa G, Hildebrandt B, Kummel S, Jungnickel K, Cho CH, Tilly W, et al. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer &gt; or =FIGO IIB &quot;bulky&quot;. International journal of radiation oncology, biology, physics. 2006;66(4):1159-67.</p>
<p>203.&nbsp;Schulze T, Wust P, Gellermann J, Hildebrandt B, Riess H, Felix R, et al. Influence of neoadjuvant radiochemotherapy combined with hyperthermia on the quality of life in rectum cancer patients. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2006;22(4):301-18.</p>
<p>204.&nbsp;Pottgen C, Levegrun S, Theegarten D, Marnitz S, Grehl S, Pink R, et al. Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006;12(1):97-106.</p>
<p>205.&nbsp;Plotkin M, Gneveckow U, Meier-Hauff K, Amthauer H, Feussner A, Denecke T, et al. 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2006;22(4):319-25.</p>
<p>206.&nbsp;Marnitz S, Kohler C, Schneider A, Seiler F, Hinkelbein W. Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2006;182(2):80-5.</p>
<p>207.&nbsp;Marnitz S, Kohler C, Muller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecologic oncology. 2006;103(3):1023-30.</p>
<p>208.&nbsp;Marnitz S, Kohler C, Fuller J, Hinkelbein W, Schneider A. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2006;182(1):45-51.</p>
<p>209.&nbsp;Marnitz S, Kohler C, Bongardt S, Braig U, Hertel H, Schneider A, et al. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecologic oncology. 2006;103(1):35-44.</p>
<p>210.&nbsp;Marnitz S, Hoecht S, Hinkelbein W. The role of radiotherapy in the management of malignant melanoma. Frontiers of radiation therapy and oncology. 2006;39:140-8.</p>
<p>211.&nbsp;Marnitz S, Cordini D, Bendl R, Lemke AJ, Heufelder J, Simiantonakis I, et al. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2006;182(7):395-9.</p>
<p>212.&nbsp;Ludemann L, Sreenivasa G, Michel R, Rosner C, Plotkin M, Felix R, et al. Corrections of arterial input function for dynamic H215O PET to assess perfusion of pelvic tumours: arterial blood sampling versus image extraction. Physics in medicine and biology. 2006;51(11):2883-900.</p>
<p>213.&nbsp;Hofmann M, Kiecker F, Wurm R, Schlenger L, Budach V, Sterry W, et al. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. Journal of neuro-oncology. 2006;76(1):59-64.</p>
<p>214.&nbsp;Hildebrandt B, Schoeler D, Ringel F, Kerner T, Wust P, Riess H, et al. Differential gene expression in peripheral blood lymphocytes of cancer patients treated with whole body hyperthermia and chemotherapy: a pilot study. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2006;22(8):625-35.</p>
<p>215.&nbsp;Hidajat N, Wust P, Kreuschner M, Felix R, Schroder RJ. Radiation risks for the radiologist performing transjugular intrahepatic portosystemic shunt (TIPS). The British journal of radiology. 2006;79(942):483-6.</p>
<p>216.&nbsp;Hidajat N, Wust P, Felix R, Schroder RJ. Radiation exposure to patient and staff in hepatic chemoembolization: risk estimation of cancer and deterministic effects. Cardiovascular and interventional radiology. 2006;29(5):791-6.</p>
<p>217.&nbsp;Grund D, Kohler C, Schneider A, Marnitz S. [Role of Laparoscopy in the Treatment of Endometrial Carcinoma]. Gynakologisch-geburtshilfliche Rundschau. 2006;46(1-2):13-24.</p>
<p>218.&nbsp;Graf R, Hildebrandt B, Tilly W, Riess H, Felix R, Budach V, et al. A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas. BMC cancer. 2006;6:30.</p>
<p>219.&nbsp;Gellermann J, Weihrauch M, Cho CH, Wlodarczyk W, Fahling H, Felix R, et al. Comparison of MR-thermography and planning calculations in phantoms. Medical physics. 2006;33(10):3912-20.</p>
<p>220.&nbsp;Gellermann J, Hildebrandt B, Issels R, Ganter H, Wlodarczyk W, Budach V, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer. 2006;107(6):1373-82.</p>
<p>221.&nbsp;Budach W, Hehr T, Budach V, Belka C, Dietz K. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC cancer. 2006;6:28.</p>
<p>222.&nbsp;Boehmer D, Maingon P, Poortmans P, Baron MH, Miralbell R, Remouchamps V, et al. Guidelines for primary radiotherapy of patients with prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2006;79(3):259-69.</p>
<p>223.&nbsp;Boehmer D, Kuczer D, Badakhshi H, Stiefel S, Kuschke W, Wernecke KD, et al. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2006;182(5):277-82.</p>
<p>224.&nbsp;Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, et al. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2005;181(1):35-41.</p>
<p>225.&nbsp;Plecko B, Hoeger H, Jakobs C, Struys E, Stromberger C, Leschnik M, et al. Pipecolic acid concentrations in brain tissue of nutritionally pyridoxine-deficient rats. Journal of inherited metabolic disease. 2005;28(5):689-93.</p>
<p>226.&nbsp;Marnitz S, Kohler C, Roth C, Fuller J, Hinkelbein W, Schneider A. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecologic oncology. 2005;99(3):536-44.</p>
<p>227.&nbsp;Klemm P, Marnitz S, Kohler C, Braig U, Schneider A. Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Gynecologic oncology. 2005;99(1):101-5.</p>
<p>228.&nbsp;Hocht S, Stark R, Seiler F, Heufelder J, Bechrakis NE, Cordini D, et al. Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2005;181(12):783-8.</p>
<p>229.&nbsp;Graf R, Hildebrandt B, Tilly W, Sreenivasa G, Ullrich R, Felix R, et al. Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy. Onkologie. 2005;28(6-7):325-30.</p>
<p>230.&nbsp;Deger S, Boehmer D, Roigas J, Schink T, Wernecke KD, Wiegel T, et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. European urology. 2005;47(4):441-8.</p>
<p>231.&nbsp;Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(6):1125-35.</p>
<p>232.&nbsp;Boehmer D, Badakhshi H, Kuschke W, Bohsung J, Budach V. Testicular dose in prostate cancer radiotherapy: impact on impairment of fertility and hormonal function. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2005;181(3):179-84.</p>
<p>233.&nbsp;Wust P, von Borczyskowski DW, Henkel T, Rosner C, Graf R, Tilly W, et al. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2004;73(1):39-48.</p>
<p>234.&nbsp;Stromberger C, Bodamer <a href="service/glossar/begriff/oa/" class="glossary"><abbr title="Oberarzt">OA</abbr></a>. Fabry disease defined. European journal of clinical investigation. 2004;34(6):449; author reply 50.</p>
<p>235.&nbsp;Senan S, De Ruysscher D, Giraud P, Mirimanoff R, Budach V, Radiotherapy Group of European Organization for R, et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2004;71(2):139-46.</p>
<p>236.&nbsp;Kaiser A, Moser L, Kuschke W, Hinkelbein M, Buchali A, Budach V. Virtual simulation of a boost field in adjuvant radiotherapy of the breast. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft&nbsp; [et al]. 2004;180(10):637-41.</p>
<p>237.&nbsp;Item CB, Mercimek-Mahmutoglu S, Battini R, Edlinger-Horvat C, Stromberger C, Bodamer O, et al. Characterization of seven novel mutations in seven patients with GAMT deficiency. Human mutation. 2004;23(5):524.</p>
<p>238.&nbsp;Dunne AA, Budach VG, Wagner W, Werner JA. Management of N0 neck in head and neck cancer: current controversies. Onkologie. 2004;27(4):363-7.</p>
<p>239.&nbsp;Deger S, Taymoorian K, Boehmer D, Schink T, Roigas J, Wille AH, et al. Thermoradiotherapy using interstitial self-regulating thermoseeds: an intermediate analysis of a phase II trial. European urology. 2004;45(5):574-9; discussion 80.</p>
<p>240.&nbsp;Classen J, Schmidberger H, Meisner C, Winkler C, Dunst J, Souchon R, et al. Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG). British journal of cancer. 2004;90(12):2305-11.</p>
<p>241.&nbsp;Boehmer D, Bohsung J, Eichwurzel I, Moys A, Budach V. Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2004;71(3):319-25.</p>

				</div>

				<!--TYPO3SEARCH_end-->  
			</main>
			<!-- main:end -->

			


<!-- mod-breadcrumb:start --><h4 class="hidden-text">Sie befinden sich hier:</h4><ul class="mod-breadcrumbs"><li itemscope itemtype="http://data-vocabulary.org/Breadcrumb"><a href="/" title="Klinik für Radioonkologie und Strahlentherapie" itemprop="url"><span itemprop="title">Startseite</span><span class="hidden-text">.</span></a></li><li itemscope itemtype="http://data-vocabulary.org/Breadcrumb"><a href="forschung/" title="Behandlungsangebote" itemprop="url"><span itemprop="title">Behandlungsangebote</span><span class="hidden-text">.</span></a></li><li itemscope itemtype="http://data-vocabulary.org/Breadcrumb"><a href="forschung/publikationen/" title="Publikationen" itemprop="url"><span itemprop="title">Publikationen</span><span class="hidden-text">.</span></a></li><li itemscope itemtype="http://data-vocabulary.org/Breadcrumb"><span itemprop="title">Publikationen der Klinik (2004-2014)</span><span class="hidden-text">.</span></li></ul><!-- mod-breadcrumb:end -->

<!-- footer:start -->
<footer>
	<p class="print-only">
		Charité Universitätsmedizin Berlin | Campus Charité Mitte | Charitéplatz 1 | D 10117 Berlin |
		<br/>
		t: +49 30 450 - 50 | www.charite.de | © Charité 2015
	</p>
	<div class="footer-content">
		<div class="row container">
			<div class="col-l-5">
				<div class="contact-wrapper">
					<h3>Kontaktieren Sie uns</h3>
					<p>Unser Sekretariat vermittelt Ihnen gerne einen kompetenten Ansprechpartner:</p>
					<p><strong>Montag-Freitag:</strong> 7.30-20.00 Uhr<br/>
						<a class="icon-phone" href="+4930450589001">+49 30 450 589 001</a>
					</p>
					<p>Oder verwenden Sie unser<br/>
						<a class="icon-mail" href="javascript:void(0);">Kontaktformular</a>
					</p>
				</div>
			</div>
			<nav class="col-l-7">
				<div class="row">
					<h4 class="hidden-text">Spezielle Seiten:</h4><div class="col-xs-12 col-s-6 col-m-4"><ul class="meta-navi"><li><a href="metas/ueberblick/" title="Überblick">Überblick</a><span class="hidden-text">.</span></li><li><a href="metas/suche/" title="Suche">Suche</a><span class="hidden-text">.</span></li><li><a href="metas/impressum/" title="Impressum">Impressum</a><span class="hidden-text">.</span></li><li><a href="metas/datenschutz/" title="Datenschutz">Datenschutz</a><span class="hidden-text">.</span></li></ul></div>
					<div class="col-xs-12 col-s-6 col-m-4">
						<div class="award-wrapper">
							<p>Unsere Auszeichnung:</p>
							<img src="fileadmin/user_upload/microsites/m_cc14/strahlentherapie/Focus_Top-Klinik_2013.png" alt="" width="80"/>
						</div>
					</div>
					<div class="col-xs-12 col-s-12 col-m-4"><h4 class="hidden-text">Service-Funktionen:</h4><ul class="service-navi"><li class="recommend">
        <!-- flyout-recommend:start -->
        <a class="icon-share" href="forschung/publikationen/publikationen_der_klinik_2004_2014/#" title="Seite weiterempfehlen">
          <span>Weiterempfehlen</span>
          <span class="hidden-text">.</span>
        </a>
        <div class="flyout">
          <div class="flyout-content">
            <strong>Seite weiterempfehlen</strong>
            <span class="hidden-text">.</span>
            <p><span>Mit diesem Link können Sie die aktuell aufgerufene Seite weiterempfehlen:</span></p>
            <input type="text" value="http://relaunch-strahlentherapie.charite.juno.artplan.local/forschung/publikationen/publikationen_der_klinik_2004_2014/">
            <a class="recommendation-mail" href="mailto:?subject=Weiterempfehlen%20Seite%26body=Ich%20empfehle%20folgenden%20Link%20auf%20www.charite.de%0A%0Ahttp://relaunch-strahlentherapie.charite.juno.artplan.local/forschung/publikationen/publikationen_der_klinik_2004_2014/">
              <span>als E-Mail versenden</span>
              <span class="hidden-text">.</span>
            </a>
            <a class="bookmark" href="forschung/publikationen/publikationen_der_klinik_2004_2014/#">
              <span>Seite bookmarken</span>
              <span class="hidden-text">.</span>
            </a>
          </div>
        </div>
        <!-- flyout-recommend:end -->
      </li><li>
      <a class="icon-print" href="javascript:window.print()" title="Seite drucken">
        <span>Seite drucken</span>
        <span class="hidden-text">.</span>
      </a>
    </li><li>
        <a class="icon-pdf" href="http://services.artplan.local/pdfgen/charite-internet/?URL=relaunch-strahlentherapie.charite.juno.artplan.local%2Fforschung%2Fpublikationen%2Fpublikationen_der_klinik_2004_2014%2F&hash=611c6a00126d4c2dcd8735e62145c936" title="PDF generieren" target="_blank">
          <span>PDF generieren</span>
          <span class="hidden-text">.</span>
        </a>
      </li></ul></div>
				</div>
			</nav>
			<p class="copyright">© Charité 2015</p>
		</div>
	</div>
</footer>
<!-- footer:end -->


		</div>
		<!-- wrapper:end -->
	</div>

	
</div>
<!--[if lte IE 8]><script src="typo3conf/ext/a21_custom/Resources/Public/js/libs/vendor/jquery/jquery.js?1443453173" type="text/javascript"></script>
<script src="typo3conf/ext/a21_custom/Resources/Public/js/libs/vendor/modernizr/modernizr.custom.min.js?1443453173" type="text/javascript"></script><![endif]-->
<script src="typo3conf/ext/a21_custom/Resources/Public/js/main.js?1445852584" type="text/javascript"></script>



</body>
</html>
<!-- Cached page generated 18-11-15 09:02. Expires 19-11-15 09:02 -->
<!-- Parsetime: 0ms -->
